Clinical Trial Update: Multicenter Single-Arm Study of Ivonescimab (AK112) Combined with Chemotherapy in Pretreated Pleural Mesothelioma [Phase 2]

View source ↗

Summary

Phase 2 multicenter single-arm trial evaluating Ivonescimab (AK112) plus chemotherapy for pretreatment malignant pleural mesothelioma; the study is actively rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma

Drugs mentioned

• Chemotherapy (standard of care) (Chemotherapy)
• Ivonescimab (AK112) (ivonescimab)

Snippet

Sponsor: The First Hospital of Jilin University | Conditions: Pretreated Pleural Mesothelioma | Phase 2 | Status: RECRUITING